A Comparison of Cox Regression and Neural Networks for Risk Stratification in Cases of Acute Lymphoblastic Leukaemia in Children
β Scribed by D. J. Groves; S. W. Smye; S. E. Kinsey; S. M. Richards; J. M. Chessells; O. B. Eden; C. C. Bailey
- Book ID
- 106175757
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 144 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0941-0643
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background Acute lymphoblastic leukaemia (ALL) represents about 30% of cancer in children and thus is the most common childhood malignancy. Despite the great progress, further improvement of treatment results remains an important problem. ## Aim A comparison of the results of standard risk a
## Abstract In a comparison of treatments for standardβrisk acute lymphoblastic leukaemia in children (UKALL III), there were no differences in remission lengths between regimens with or without secondβline drugs (cytosine arabinoside and asparaginase) and with continuous or discontinuous mercaptop
Methotrexate (MTX) infusions of 500-1,000 mg/m2 over 24 hours may improve survival and prevent relapse in children with acute lymphoblastic leukemia (ALL). Childrens Cancer Group (CCG) Study 139 compared weekly oral methotrexate 20 mg/m2/ week (oral MTX) to MTX 500 mg/m2 infused over 24 hours (IV MT